open access

Vol 92, No 3 (2021)
Guidelines / Expert consensus
Get Citation

The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice

Artur Rogowski123, Bartosz Dybowski4, Edyta Wlazlak5, Wlodzimierz Baranowski6, Tomasz Rechberger7, Klaudia Stangel-Wojcikiewicz8, Magdalena E. Grzybowska9, Tomasz Kluz10, Elzbieta Narojczyk-Swiesciak11, Monika Szafarowska6, Zofia Rozpendowska5, Grzegorz Surkont5
DOI: 10.5603/GP.2021.0045
·
Pubmed: 33844242
·
Ginekol Pol 2021;92(3):230-235.
Affiliations
  1. Department of Gynecology, „Inflancka” Specialist Hospital, Warsaw, Poland
  2. Cardinal Stefan Wyszynski University in Warsaw, Faculty of Medicine, Collegium Medicum, Warsaw, Poland
  3. Department of Obstetrics and Gynecology, Mother and Child Institute, Warsaw, Poland
  4. Department of Urology, Roefler Memorial Hospital, Pruszkow, Poland
  5. Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland
  6. Department of Gynecology and Oncological Gynecology Military Institute of Medicine, Warsaw, Poland
  7. II Department of Gynecology, Medical University of Lublin, Poland
  8. Jagiellonian University Medical College, Department of Gynecology and Oncology, Cracow, Poland
  9. Department of Gynecology, Gynecological Oncology and Gynecological Endocrinology, Medical University of Gdansk, Poland
  10. Department of Gynecology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
  11. II Department of Obstetrics and Gynecology Centre of Postgraduate Medical Education Bielański Hospital, Warsaw, Poland

open access

Vol 92, No 3 (2021)
RECOMMENDATIONS

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. Material and methods: A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Results: Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Conclusions: Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. Material and methods: A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Results: Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Conclusions: Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.

Get Citation

Keywords

urodynamics, stress urinary incontinence, overactive bladder, voiding dysfunction, bladder outlet obstruction, guidelines

About this article
Title

The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice

Journal

Ginekologia Polska

Issue

Vol 92, No 3 (2021)

Article type

Guidelines / Expert consensus

Pages

230-235

DOI

10.5603/GP.2021.0045

Pubmed

33844242

Bibliographic record

Ginekol Pol 2021;92(3):230-235.

Keywords

urodynamics
stress urinary incontinence
overactive bladder
voiding dysfunction
bladder outlet obstruction
guidelines

Authors

Artur Rogowski
Bartosz Dybowski
Edyta Wlazlak
Wlodzimierz Baranowski
Tomasz Rechberger
Klaudia Stangel-Wojcikiewicz
Magdalena E. Grzybowska
Tomasz Kluz
Elzbieta Narojczyk-Swiesciak
Monika Szafarowska
Zofia Rozpendowska
Grzegorz Surkont

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl